A multi-stock news day sees Trump pressure Apple's Tim Cook on manufacturing, Eli Lilly rally on positive drug trial data, and MongoDB surge after hours on earnings beat. Each story carries a distinct catalyst but the headline bundles them, limiting clean trade precision.
MDB's 71.7% gross margins and 22.8% revenue growth to $2.5B suggest durable platform economics that could sustain post-earnings multiple expansion if the beat came with raised guidance.
MDB remains net-loss negative (-$0.88 diluted EPS) and trades on growth momentum alone, meaning any guidance miss or macro multiple compression could rapidly erase the after-hours gain; AAPL's $416.2B revenue base and 46.9% gross margin provide a cushion but political/tariff risk on Cook specifically adds supply-chain uncertainty.